IL6 and cancer: Despite the fact that different cellular sources are being used for CAF-tumour in vitro studies, some common pathways are being described for CAFs in primary and secondary cancers such as the involvement of pro-fibrogenic growth factor TGF-β [56,76,78,82] and inflammatory cytokine IL-6 [72,83].